These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 22697595)

  • 1. Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis.
    Giuliano C; Wilhelm SM; Kale-Pradhan PB
    Expert Rev Clin Pharmacol; 2012 May; 5(3):337-44. PubMed ID: 22697595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of community-acquired pneumonia in veteran patients to whom proton pump inhibitors were dispensed.
    Hermos JA; Young MM; Fonda JR; Gagnon DR; Fiore LD; Lawler EV
    Clin Infect Dis; 2012 Jan; 54(1):33-42. PubMed ID: 22100573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia.
    de Jager CP; Wever PC; Gemen EF; van Oijen MG; van Gageldonk-Lafeber AB; Siersema PD; Kusters GC; Laheij RJ
    Aliment Pharmacol Ther; 2012 Nov; 36(10):941-9. PubMed ID: 23034135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of proton pump inhibitors induced risk of community-acquired pneumonia.
    Nguyen PA; Islam M; Galvin CJ; Chang CC; An SY; Yang HC; Huang CW; Li YJ; Iqbal U
    Int J Qual Health Care; 2020 Jun; 32(5):292-299. PubMed ID: 32436582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs.
    Eurich DT; Sadowski CA; Simpson SH; Marrie TJ; Majumdar SR
    Am J Med; 2010 Jan; 123(1):47-53. PubMed ID: 20102991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with proton pump inhibitors in acute non-variceal upper gastrointestinal bleeding: a meta-analysis.
    Khuroo MS; Khuroo MS; Farahat KL; Kagevi IE
    J Gastroenterol Hepatol; 2005 Jan; 20(1):11-25. PubMed ID: 15610441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis: proton pump inhibitor use and the risk of community-acquired pneumonia.
    Johnstone J; Nerenberg K; Loeb M
    Aliment Pharmacol Ther; 2010 Jun; 31(11):1165-77. PubMed ID: 20222914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbial evaluation of proton-pump inhibitors and the risk of pneumonia.
    Meijvis SC; Cornips MC; Voorn GP; Souverein PC; Endeman H; Biesma DH; Leufkens HG; van de Garde EM
    Eur Respir J; 2011 Nov; 38(5):1165-72. PubMed ID: 21478217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis.
    Lambert AA; Lam JO; Paik JJ; Ugarte-Gil C; Drummond MB; Crowell TA
    PLoS One; 2015; 10(6):e0128004. PubMed ID: 26042842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis.
    Janarthanan S; Ditah I; Adler DG; Ehrinpreis MN
    Am J Gastroenterol; 2012 Jul; 107(7):1001-10. PubMed ID: 22710578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perils and pitfalls of long-term effects of proton pump inhibitors.
    Wilhelm SM; Rjater RG; Kale-Pradhan PB
    Expert Rev Clin Pharmacol; 2013 Jul; 6(4):443-51. PubMed ID: 23927671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis.
    Deshpande A; Pant C; Pasupuleti V; Rolston DD; Jain A; Deshpande N; Thota P; Sferra TJ; Hernandez AV
    Clin Gastroenterol Hepatol; 2012 Mar; 10(3):225-33. PubMed ID: 22019794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
    Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
    Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study.
    Gulmez SE; Holm A; Frederiksen H; Jensen TG; Pedersen C; Hallas J
    Arch Intern Med; 2007 May; 167(9):950-5. PubMed ID: 17502537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considerations for the use of proton-pump inhibitors in older adults.
    Desilets AR; Asal NJ; Dunican KC
    Consult Pharm; 2012 Feb; 27(2):114-20. PubMed ID: 22330952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitors: bacterial pneumonia.
    Prescrire Int; 2012 Sep; 21(130):210-2. PubMed ID: 23016253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis.
    Park CH; Kim EH; Roh YH; Kim HY; Lee SK
    PLoS One; 2014; 9(11):e112558. PubMed ID: 25394217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton-pump inhibitor use and the risk for community-acquired pneumonia.
    Sarkar M; Hennessy S; Yang YX
    Ann Intern Med; 2008 Sep; 149(6):391-8. PubMed ID: 18794558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.
    Higginbotham TW
    Ann Pharmacother; 2010 Mar; 44(3):572-6. PubMed ID: 20124466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton Pump Inhibitors and the Risk of Community-Acquired Pneumonia: An Updated Meta-analysis.
    Xun X; Yin Q; Fu Y; He X; Dong Z
    Ann Pharmacother; 2022 May; 56(5):524-532. PubMed ID: 34425689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.